Centaurus Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $885K | Sell |
36,772
-1,278
| -3% | -$33.4K | 0.03% | 435 |
|
|
2026
Q1 | $1.07M | Sell |
38,050
-2,434
| -6% | -$64.8K | 0.05% | 320 |
|
|
2025
Q4 | $1.01M | Sell |
40,484
-7,851
| -16% | -$198K | 0.05% | 344 |
|
|
2025
Q3 | $1.23M | Sell |
48,335
-3,960
| -8% | -$97.7K | 0.06% | 284 |
|
|
2025
Q2 | $1.27M | Sell |
52,295
-9,532
| -15% | -$222K | 0.07% | 258 |
|
|
2025
Q1 | $1.57M | Sell |
61,827
-725
| -1% | -$19K | 0.09% | 201 |
|
|
2024
Q4 | $1.66M | Sell |
62,552
-1,991
| -3% | -$54K | 0.1% | 193 |
|
|
2024
Q3 | $1.87M | Buy |
64,543
+2,130
| +3% | +$62.1K | 0.12% | 164 |
|
|
2024
Q2 | $1.75M | Sell |
62,413
-1,195
| -2% | -$32.9K | 0.12% | 168 |
|
|
2024
Q1 | $1.76M | Sell |
63,608
-3,629
| -5% | -$101K | 0.12% | 162 |
|
|
2023
Q4 | $1.94M | Buy |
67,237
+1,914
| +3% | +$57.9K | 0.15% | 144 |
|
|
2023
Q3 | $2.17M | Sell |
65,323
-1,197
| -2% | -$42.3K | 0.19% | 123 |
|
|
2023
Q2 | $2.44M | Sell |
66,520
-27,264
| -29% | -$1.06M | 0.21% | 122 |
|
|
2023
Q1 | $3.83M | Sell |
93,784
-3,910
| -4% | -$169K | 0.31% | 78 |
|
|
2022
Q4 | $5.01M | Sell |
97,694
-4,647
| -5% | -$223K | 0.47% | 48 |
|
|
2022
Q3 | $4.48M | Sell |
102,341
-5,702
| -5% | -$277K | 0.44% | 47 |
|
|
2022
Q2 | $5.67M | Buy |
108,043
+6,975
| +7% | +$355K | 0.56% | 32 |
|
|
2022
Q1 | $5.23M | Buy |
101,068
+18,195
| +22% | +$944K | 0.41% | 51 |
|
|
2021
Q4 | $4.89M | Buy |
82,873
+922
| +1% | +$45.7K | 0.37% | 57 |
|
|
2021
Q3 | $3.52M | Sell |
81,951
-3,137
| -4% | -$139K | 0.3% | 83 |
|
|
2021
Q2 | $3.33M | Buy |
85,088
+26,704
| +46% | +$1.04M | 0.28% | 85 |
|
|
2021
Q1 | $2.12M | Buy |
58,384
+5,841
| +11% | +$207K | 0.21% | 126 |
|
|
2020
Q4 | $1.93M | Buy |
52,543
+10,150
| +24% | +$372K | 0.2% | 116 |
|
|
2020
Q3 | $1.48M | Sell |
42,393
-10,595
| -20% | -$371K | 0.2% | 118 |
|
|
2020
Q2 | $1.64M | Sell |
52,988
-1,535
| -3% | -$52.1K | 0.24% | 109 |
|
|
2020
Q1 | $1.69M | Buy |
54,523
+5,508
| +11% | +$188K | 0.34% | 80 |
|
|
2019
Q4 | $1.82M | Buy |
49,015
+8,957
| +22% | +$319K | 0.26% | 93 |
|
|
2019
Q3 | $1.37M | Sell |
40,058
-384
| -0.9% | -$14K | 0.21% | 118 |
|
|
2019
Q2 | $1.66M | Buy |
40,442
+663
| +2% | +$26.3K | 0.26% | 93 |
|
|
2019
Q1 | $1.6M | Buy |
39,779
+1,835
| +5% | +$73.5K | 0.27% | 94 |
|
|
2018
Q4 | $1.55M | Buy |
37,944
+5,270
| +16% | +$219K | 0.34% | 76 |
|
|
2018
Q3 | $1.36M | Sell |
32,674
-38,783
| -54% | -$1.49M | 0.25% | 102 |
|
|
2018
Q2 | $2.46M | Buy |
71,457
+63,876
| +843% | +$2.18M | 0.34% | 67 |
|
|
2018
Q1 | $255K | Buy |
7,581
+588
| +8% | +$20.2K | 0.06% | 282 |
|
|
2017
Q4 | $240K | Buy |
+6,993
| New | +$238K | 0.06% | 271 |
|
Other funds holding PFE
Centaurus Financial's PFE Position: Q2 2026 in Review
Centaurus Financial reduced its Pfizer (PFE) stake by 3.4% in Q2 2026, selling an estimated $33.4K and leaving 36,772 shares worth $885K. The position accounts for 0.03% of the portfolio, ranked #435.
Centaurus Financial first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.67M in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centaurus Financial held 36,772 shares of Pfizer worth $885K as of Q2 2026.
- Centaurus Financial sold 1,278 Pfizer shares in Q2 2026, an estimated $33.4K.
- Pfizer made up 0.03% of Centaurus Financial's portfolio in Q2 2026, its #435 holding.
- Centaurus Financial first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Centaurus Financial's Pfizer position peaked at $5.67M in Q2 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.